Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
- Ronit Gurion
- , Uri Rozovski
- , Gilad Itchaki
- , Anat Gafter-Gvili
- , Chiya Leibovitch
- , Pia Raanani
- , Haim Ben-Zvi
- , Moran Szwarcwort
- , Mor Taylor-Abigadol
- , Eldad J. Dann
- , Nurit Horesh
- , Tsofia Inbar
- , Inna Tzoran
- , Noa Lavi
- , Riva Fineman
- , Shimrit Ringelstein-Harlev
- , Netanel A. Horowitz
- Rabin Medical Center Israel
- Tel Aviv University
- Rambam Health Care Campus Israel
- Technion-Israel Institute of Technology
Research output: Contribution to journal › Article › peer-review
45
Scopus
citations